VANGUARD GROUP INC - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 35 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$615,471
-23.0%
976,938
+1.5%
0.00%
Q2 2023$799,072
+158.9%
962,738
+37.2%
0.00%
Q1 2023$308,697
-25.4%
701,5840.0%0.00%
Q4 2022$413,864
-15.7%
701,584
+0.1%
0.00%
Q3 2022$491,000
-53.1%
701,003
-2.9%
0.00%
Q2 2022$1,046,000
-61.4%
721,651
+0.1%
0.00%
Q1 2022$2,712,000
-49.2%
721,151
+5.6%
0.00%
Q4 2021$5,334,000682,9720.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
First PREMIER Bank 807,535$4760.14%
Warberg Asset Management LLC 370,370$218,5180.03%
METEORA CAPITAL, LLC 134,524$79,3560.02%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 149,774$88,3520.02%
SILVER OAK SECURITIES, INCORPORATED 51,941$310.01%
Veritable, L.P. 506,513$298,7920.01%
Shaolin Capital Management LLC 236,621$1400.00%
Elgethun Capital Management 14,796$9,1710.00%
LGL PARTNERS, LLC 23,000$13,5680.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$49,5520.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders